Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine

Clicks: 434
ID: 118456
2003
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
The use of the pneumococcal conjugate vaccine is preventing disease in young children, for whom the vaccine is indicated, and may be reducing the rate of disease in adults. The vaccine provides an effective new tool for reducing disease caused by drug-resistant strains.
Reference Key
cg2003thedecline Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Whitney CG;Farley MM;Hadler J;Harrison LH;Bennett NM;Lynfield R;Reingold A;Cieslak PR;Pilishvili T;Jackson D;Facklam RR;Jorgensen JH;Schuchat A; ;;
Journal The New England journal of medicine
Year 2003
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/12724479
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support u.s. gov't adult adolescent aged middle aged united states / epidemiology Child Infant P.H.S. preschool Incidence Evaluation Study population surveillance vaccines serotyping pneumococcal infections / epidemiology* pneumococcal infections / prevention & control* pneumococcal infections / microbiology penicillin resistance streptococcus pneumoniae / classification streptococcus pneumoniae / isolation & purification pneumococcal vaccines* conjugate heptavalent pneumococcal conjugate vaccine streptococcus pneumoniae / drug effects pmid:12724479 doi:10.1056/nejmoa022823 cynthia g whitney monica m farley active bacterial core surveillance of the emerging infections program network meningococcal vaccines*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.